This chelation reaction can occur in both intra- and extra-cellular environments due to the lipophilic properties of dimercaprol, but it is most prominent within extracellular compartments
Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will
Results should be interpreted with a qualified healthcare provider to understand what your genetic profile may mean for semaglutide tolerability, titration strategy, and monitoring priorities
This supports recovery, lean muscle retention, better sleep, and even skin elasticity
Inclusion of GLP-1 agonists regardless of history of obesity reduced HRs and narrowed CIs but did not change the significance of the results (Table 2)